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We report that eight heterozygous missense muta-
tions in TUBB3, encoding the neuron-specific
b-tubulin isotype III, result in a spectrum of human
nervous system disorders that we now call the
TUBB3 syndromes. Each mutation causes the ocular
motility disorder CFEOM3, whereas some also result
in intellectual and behavioral impairments, facial
paralysis, and/or later-onset axonal sensorimotor
polyneuropathy. Neuroimaging reveals a spectrum
of abnormalities including hypoplasia of oculomotor
nerves and dysgenesis of the corpus callosum, ante-
rior commissure, and corticospinal tracts. A knock-in
diseasemousemodel reveals axon guidance defects
without evidence of cortical cell migration abnormal-
ities. We show that the disease-associated muta-
tions can impair tubulin heterodimer formation
in vitro, although folded mutant heterodimers can
still polymerize into microtubules. Modeling each
mutation in yeast tubulin demonstrates that all alter
dynamic instability whereas a subset disrupts the
interaction of microtubules with kinesin motors.
These findings demonstrate that normal TUBB3 is
required for axon guidance and maintenance in
mammals.
INTRODUCTION
Nervous system development is highly dependent upon the
microtubule cytoskeleton. Microtubules are copolymers assem-
bled from tubulin heterodimers, which contain several different
a- and b-tubulin isotypes encoded by separate genes (Lopataand Cleveland, 1987). Microtubule behavior varies according
to isotype composition, suggesting that each isotype may have
properties necessary for specific cellular functions (Joshi and
Cleveland, 1990; Luduena, 1993); however, precise functions
for most tubulin isotypes remain poorly characterized. b-tubulin
isotype III (TUBB3), one of at least six b-tubulins found in
mammals, is distinct because purified microtubules enriched in
TUBB3 are considerably more dynamic than those composed
from other b-tubulin isotypes (Panda et al., 1994), and because
its expression is primarily limited to neurons (Katsetos et al.,
2003). TUBB3 expression is greatest during periods of axon
guidance and maturation; levels decrease in the adult central
nervous system (CNS) but remain high in the peripheral nervous
system (PNS) (Jiang and Oblinger, 1992). Thus, the unique
dynamic properties and spatio-temporal expression pattern of
TUBB3 suggest that it could have a specific function for nervous
system development and axon maintenance.
The development of human brainstem ocular motor neurons is
particularly vulnerable to gene mutations that affect cytoskeletal
proteins and axon guidance (Miyake et al., 2008; Yamada et al.,
2003). Congenital fibrosis of the extraocular muscles type 3
(CFEOM3) is a rare ocular motility disorder in which affected indi-
viduals are born with blepharoptosis (drooping eyelids) and
restricted eye movements (Doherty et al., 1999; Mackey et al.,
2002). Using CFEOM3 as a marker for gene mutations that regu-
late human nervous system development and function, we now
report that eight different heterozygous missense mutations in
TUBB3, also known as TuJ1, result in CFEOM3 in isolation or
as a component of several previously undefined neurological
syndromes. Neuroradiological and pathological findings in
humans and a knock-in mouse model, respectively, demon-
strate that TUBB3 is necessary for guidance of commissural
fibers and cranial nerves. Furthermore, disease-associated
mutations can alter microtubule dynamics, and a subset per-
turbs the interaction of microtubules with kinesin motor proteins.Cell 140, 74–87, January 8, 2010 ª2010 Elsevier Inc. 75
Thus, our work to define the TUBB3 syndromes establishes the
requirement for a neuronal b-tubulin isotype in axon guidance
and normal brain development.
RESULTS
Eight Heterozygous TUBB3 Mutations Alter Six Amino
Acid Residues
CFEOM3 in the absence of additional neurological signs or
symptoms (‘‘isolated CFEOM3’’) is an 90% penetrant auto-
somal dominant disorder that had previously been mapped to
chromosome 16q in pedigrees BN and DP (OMIM#600638,
Figure S1A, Tables S1A and S1B) (Doherty et al., 1999; Mackey
et al., 2002). The critical region for the CFEOM3 gene was 3.5 Mb
and flanked by D16S498-16qter. To identify the CFEOM3 gene,
we screened coding exons and intron-exon boundaries of
positional candidates in probands from BN, DP, and additional
families with isolated CFEOM3. We identified three heterozygous
TUBB3 missense changes in 15 unrelated pedigrees: 784C > T
(R262C) in 11 pedigrees, 904G > A (A302T) in 3 pedigrees, and
185G > A (R62Q) in 1 pedigree (Figure S1B, Tables S1B–S1D).
We had ascertained study participants with CFEOM and addi-
tional neurological symptoms and, given the pan-neuronal
expression of TUBB3 in humans (http://www.hudsen.org, HUD-
SEN Human Gene Expression Spatial Database, ID: 411), we
next sequenced DNA from these probands. We identified 5
additional heterozygous TUBB3 missense changes in 13 unre-
lated pedigrees. 1249G > C (D417H) and 1249G > A (D417N)
alter the same residue and cosegregate in a dominant fashion
in 1 and 4 pedigrees, respectively. The remaining mutations,
1138C > T (R380C), 785G > A (R262H), and 1228G > A (E410K),
were found in 1, 2, and 6 pedigrees, respectively, and each arose
de novo as sporadic disease or from presumed germline mosa-
icism (Figure S1B, Tables S1A and S1E). Each of the eight muta-
tions segregated with the TUBB3 phenotype, was absent in
parents of sporadic individuals, and was not present on over
1700 control chromosomes. The independent nature of the
recurrent mutations is supported by de novo occurrences, ethnic
and geographic diversity among probands, and multiple
disease-associated haplotypes (Table S1C).
TUBB3 Mutations Can Result in Congenital Oculomotor
Nerve Hypoplasia and Later-Onset Peripheral Axon
Degeneration
Congenital ocular motility defects resulting from R262C, A302T,
R380C, and D417N amino acid substitutions ranged from mild
to severe (Figures 1A–1E), as previously described for pedigree
BN (Doherty et al., 1999), whereas all participants with R262H,
E410K, and D417H had severe CFEOM3 and congenital facial
weakness (Figures 1G and 1H). Many subjects had aberrant
eye movements and several had ptotic eyelid elevation associ-
ated with synkinetic jaw movements (Marcus Gunn phenom-
enon), clinical manifestations of aberrant innervation of cranial
musculature by the trigeminal nerve. We conducted magnetic
resonance (MR) imaging of the intracranial motor nerves and
orbital contents of affected members of four R262C or D417N
pedigrees. Similar to imaging of individuals with KIF21A
missense mutations (Demer et al., 2005), which cause the iso-76 Cell 140, 74–87, January 8, 2010 ª2010 Elsevier Inc.lated oculomotility disorder CFEOM1 (Yamada et al., 2003), we
found hypoplasia of the oculomotor nerve and the muscles inner-
vated by its superior division—the levator palpebrae superioris
and superior rectus—as well as the medial rectus muscle inner-
vated by its inferior division (Figures 1J–1L, Figure S1C). The
oculomotor nerve also aberrantly innervated the lateral rectus
muscle, normally innervated by the abducens nerve. Thus, ocular
motility restrictions and/or synkinetic lid elevation with jaw
movements could be explained by axon guidance defects.
All subjects harboring D417H or R262H were born with
congenital wrist and finger contractures, suggesting maldevel-
opment of spinal motor neurons (Figure 1I), and developed lower
extremity weakness and sensory loss in the first decade of life.
Most subjects harboring D417N and the oldest patient harboring
E410K developed lower extremity weakness and sensory loss in
the second to third decade, all in the absence of congenital
contractures (Figure 1F). Electromyography revealed chronic,
generalized sensorimotor polyneuropathy that was predomi-
nantly axonal and diagnosed as Charcot-Marie-Tooth Type 2
(CMT2) in some subjects. Several participants harboring
D417N without CFEOM3 developed polyneuropathy (Table
S1E), suggesting that TUBB3 mutations can cause an isolated
CMT2-like disorder.
TUBB3 Mutations Can Result in Commissural Axon
and Basal Ganglia Malformations that Segregate
with Developmental Disabilities
Brain imaging was reviewed from individuals with each TUBB3
mutation except D417H and appeared normal only in the R62Q
subject. Common findings were dysgenesis of the corpus cal-
losum (CC), anterior commissure (AC), and internal capsule;
generalized loss of white matter; and basal ganglia dysmor-
phisms that correlated with specific mutations (Figure 2). No
images showed cortical dysplasia or evidence of cortical migra-
tion defects. Intellectual and behavioral impairments generally
correlated with the severity of CC dysgenesis. Individuals with
A302T, E410K, R262H, and R380C had more severe CC dysgen-
esis and mild to moderate intellectual, social, and behavioral
impairments. By contrast, those with R62Q, R262C, or D417N
substitutions had absent or mild CC dysgenesis and most
were developmentally normal (Table S1).
R262C Tubb3 Substitution Results in Impaired Axon
Guidance but Normal Cortical Architecture in Mice
To further examine the nature of the nervous system defects in
humans, we generated a disease mouse model harboring the
most common amino acid substitution (R262C) (Figure S2A).
Wild-type (WT) and Tubb3+/R262C mice were born at the
expected Mendelian frequencies; heterozygous mice appeared
healthy, did not display external eye phenotypes, and had histo-
logically normal appearing brains. Similarly, the R262C pheno-
type in humans can be nonpenetrant and, when penetrant, is
limited to CFEOM3. By contrast, Tubb3R262C/R262C mice failed
to breathe normally and died within hours of birth. Overall brain
size was similar between WT and Tubb3R262C/R262C littermates,
although basal ganglia asymmetries were sometimes present.
Histological analysis at E18.5 revealed normal cortical
layer thickness and architecture in both homozygous and
Figure 1. Clinical Spectrum and Orbital
Imaging of the TUBB3 Syndromes
(A–I) Study participant photographs. R262C can
cause bilateral ptosis and severe CFEOM3 with
the resting position of both eyes infraducted and
abducted (A), moderate CFEOM3 that can be
unilateral (B), and mild CFEOM3 (not shown). A
similar spectrum is seen with D417N; severe
CFEOM3 is shown in (E). A302T (C) and R380C
(D) cause moderate to severe CFEOM3. Partici-
pants in (A)–(E) have full facial movements. The
axonal neuropathy in the participant with D417N
(E) results in atrophy of the intrinsic foot muscles
and a high arch (F). E410K (G) and R262H (H) result
in severe CFEOM3 and facial weakness, and
R262H also results in congenital ulnar deviation
of the hand with joint contractures of the thumbs
and fingers (I).
(J–L) MRI of the brainstem at the level of the oculo-
motor nerve (J) and orbital contents posterior to
the globe (K) in a participant with predominantly
left-sided CFEOM3 and a D417N substitution.
Note unilateral hypoplasia of the left oculomotor
nerve (J, arrow) and the atrophy of the levator pal-
pebrae superioris (LPS), superior rectus (SR), and
medial rectus (MR) muscles in (K). The inferior
rectus (IR), lateral rectus (LR), and superior oblique
(SO) muscles appear normal. (L) Control orbital
MRI for comparison. ON denotes optic nerve.
See also Figure S1 and Table S1.heterozygous mice versus WT littermates, and neocortical layer-
specific markers confirmed that layering was preserved (Figures
3A–3H, Figure S2C). The hippocampus and dentate gyrus also
appeared normal (Figure S2B). Thus, consistent with human
MR findings, heterozygous and homozygous R262C mice do
not show evidence of cortical cell migration defects.
Tubb3R262C/R262C mice showed defects in the guidance of
commissural axons and cranial nerves. There was significant
thinning and/or absent midline crossing of the AC throughout
its anterior-posterior axis compared to WT mice; it appeared
tortuous and often had aberrant fiber projections at the midline.
The AC was also thinner at the midline in Tubb3+/R262C mice, as
found in human patients (Figures 3I and 3K, Figure S2D). Agen-
esis of the CC with bundles of stalled axons (Probst bundles)
adjacent to the midline was observed in 2/5 homozygous mutant
mice, both of which were on a mixed C57BL/6J:129S6 back-Cell 140, 74–ground (Figures 3J and 3L). By contrast,
CC morphology was normal in all 18
mixed background WT mice analyzed.
In the three homozygous mice in which
the CC crossed the midline, it appeared
abnormally thin in two and thick in one
(Figure 3K). Whole-mount neurofilament
staining at embryonic day (E) 11.5–E12
revealed numerous defects in the guid-
ance and branching of cranial nerves
(Figures 3M–3P). The oculomotor nerve
failed to reach the correct muscle anlage
and instead projected toward the positionof the superior oblique muscle that is normally innervated by the
trochlear nerve. Trochlear nerve growth was often stalled, and
the trigeminal nerve failed to grow and branch properly
compared to WT littermates. These data strongly support
a primary defect in the guidance of axons.
Tubb3R262C/R262C Mice Have Increased Microtubule
Stability andDecreasedKif21aMicrotubule Interactions
There was a decrease in the level of TUBB3 protein in
Tubb3R262C/R262C and Tubb3+/R262C versus WT mice. Although
protein levels in homozygous mutant mice were approximately
30% of WT values, remaining mutant protein incorporated
into microtubules that were polymerized in vitro from brain
extracts, as well as into microtubules throughout the cytoskel-
eton of dissociated cortical and hippocampal neurons (Figures
4A, 4B, and 4D). Because Tubb3 is thought to be the most87, January 8, 2010 ª2010 Elsevier Inc. 77
Figure 2. Spectrum of Human Brain Malfor-
mations Correlate with Specific TUBB3
Mutations
(A–G) Midline sagittal MRI showing the spectrum
of corpus callosum (CC) dysgenesis; correspond-
ing amino acid substitutions are noted to the
left. R62Q (A) and most R262C (B) participants
have normal CC development, whereas D417N
subjects have hypoplasia of the posterior body
(C, arrow). Subjects with A302T, E410K, and
R262H have diffuse CC hypoplasia (D–F). (G)
Both R380C siblings have CC agenesis and
brainstem (arrow) and mild vermian hypoplasia
(asterisk).
(H–N) Axial MRI from the same patient scans
showing the spectrum of anterior commissure
(AC) dysgenesis and overall loss of white matter
compared to the normal R62Q scan (H, arrow indi-
cates AC). (I–L) Subjects have hypoplastic AC.
R262H (M) and R380C (N) patient scans show
AC agenesis and dysmorphic basal ganglia. The
anterior limb of the left internal capsule is hypo-
plastic in R262H (M, arrow), whereas there is lack
of clear separation between the caudate and puta-
men and bilateral hypoplasia of the anterior limbs
of the internal capsule with R380C (N, arrows).
(A0–H0) Anterior (A0–D0) and posterior (E0–H0)
coronal sections showing the spectrum of basal
ganglia dysmorphisms present in individuals with
R262C, R262H, and R380C substitutions. (A0–D0)
Compared to a TUBB3+/+ scan (A0), R262C reveals
asymmetric basal ganglia with enlargement of the
left caudate head and putamen (B0, arrow). (C0) The
twin of the R262H patient in (F) and (M) has
dysgenesis of the left and right anterior limbs of
the internal capsule (C0, arrows), apparent fusion
of an enlarged left caudate head with the putamen,
and dilatation of the left and right anterior horn of
the lateral ventricle. (D0) The older sibling of the
patient scanned in (G) and (N) harboring an
R380C substitution has hypoplasia of the anterior
limb of the internal capsule (D0, arrow) and fusion
of the left caudate head and underlying putamen.
(E0–H0 ) Coronal MRI at the level of the caudate
body and lateral ventricles is normal in (E0).
R262C and R262H subjects have hypoplasia of
the left caudate body (F0 and G0, arrows) and tail,
and the R262H patient has dilatation of the left
lateral ventricle. (H0) The R380C patient has bilat-
eral hypoplasia of the caudate body and tail, with
Probst bundles of callosal axons that line the
bodies of the lateral ventricles (arrowheads).dynamic b-tubulin isotype, we asked whether protein loss
and/or the remaining mutant protein altered microtubule stability
in the brain. We detected an approximate 30% increase in the
levels of de-tyrosinated a-tubulin (Figure 4C), a posttranslational
modification that is indicative of stable microtubules (Webster
et al., 1987). We also measured the steady-state level of tubu-
lin polymerization in brain extracts from WT and homozygous
mutant littermates. Although overall b-tubulin levels were
decreased in Tubb3R262C/R262C brain lysates, there was an78 Cell 140, 74–87, January 8, 2010 ª2010 Elsevier Inc.increase in the amount of tubulin polymerization as detected
by a larger microtubule pellet (Figure 4D). Taken together,
these data suggest that microtubule stability is increased in
Tubb3R262C/R262C mutants.
We next asked whether Kif21a microtubule interactions are
altered in Tubb3R262C/R262C mutants because heterozygous
mutations in this kinesin in humans cause isolated ocular motor
dysfunction with clinical and neuroradiological signs of cranial
nerve axon guidance defects (Demer et al., 2005; Yamada
Figure 3. TUBB3R262C/R262C Mice Have
Normal Cortical Layering but Show Defects
in Axon Guidance
(A–D, n = 5) WT and TUBB3R262C/R262C (E–H, n = 5)
E18.5 coronal sections immunostained with
markers specific for cortical layers show that the
cortex has developed properly. Mild midline
changes result from large Probst bundles (pb),
comprised of stalled commissural axons adjacent
to the midline.
(I and K) Coronal sections from E18.5 WT (I, n = 4)
and TUBB3R262C/R262C (K, n = 5) embryos show
that the anterior commissure (red arrow) appears
broken and fails to cross the midline, whereas
the CC has crossed but is abnormally thick (red
arrowhead) in the mutant.
(J and L) E18.5 coronal sections from embryos
immunostained with the axonal marker L1 show
Probst bundles in a TUBB3R262C/R262C (L, arrow-
heads) mutant compared to WT (J).
(M–P) Whole-mount neurofilament staining of
E11.5–E12 WT (M and N, n = 13) and
TUBB3R262C/R262C (O and P, n = 6) embryos.
Mutant oculomotor (III) and trochlear (IV) nerves,
as well the maxillary (Vm) and ophthalmic (Vo) divi-
sions of the trigeminal nerve are stalled at E11.5
(O) compared to WT (M). At E12, the mutant oculo-
motor nerve follows an aberrant course adjacent
to the trochlear nerve (P) compared to WT (N).
CC = corpus callosum; e = eye; asterisk (*) = distal
tip of oculomotor nerve.
See also Figure S2.et al., 2003). We analyzed the ability of Kif21a to copurify with
microtubules isolated from the brains of Tubb3R262C/R262C
mutant and WT littermates in the presence of adenosine triphos-
phate (ATP). A significant decrease of Kif21a was detected with
microtubules from the brains of Tubb3R262C/R262C mice (Fig-
ure 4E). Thus, reduced Tubb3 microtubule incorporation and/
or the residual mutant protein affect the ability of Kif21a to
interact with microtubules and may contribute to oculomotor
nerve misguidance in mice and humans. Commissural axon
guidance defects and other TUBB3 disease-specific pheno-
types not found in CFEOM1 patients suggest that additionalCell 140, 74–motors and/or microtubule-associated
proteins (MAPs) beyond Kif21a may also
be affected.
TUBB3 Mutants Show Variable
Reductions in Heterodimer
Formation but Form Microtubules
in Mammalian Cells
A series of interactions with protein chap-
erones fold quasi-native tubulin mono-
mers into functional ab-tubulin hetero-
dimers that can then polymerize into
microtubules (Lewis et al., 1996). Point
mutations in a- and b-tubulin can impair
interactions with chaperone proteins,
resulting in reduced heterodimer forma-tion in mammalian cells (Jaglin et al., 2009; Keays et al., 2007)
and could explain low protein levels observed in mutant mice.
Thus, we asked whether R262C and the other seven substitu-
tions affect the formation of TUBB3 heterodimers.
The coding sequences of WT and all eight TUBB3 mutants
were fused to a C-terminal V5 epitope tag (TUBB3-V5) and
expressed in rabbit reticulocyte lysate. This lysate is a cell-free
system that contains necessary molecular chaperone proteins
for de novo tubulin heterodimer formation (Cleveland et al.,
1978); resulting heterodimers are comprised of rabbit a-tubulin
and WT or mutant TUBB3-V5. WT and mutant proteins were87, January 8, 2010 ª2010 Elsevier Inc. 79
Figure 4. TUBB3R262C/R262C Mice Have Low TUBB3 Protein Levels, Altered Microtubule Stability, and Decreased Kif21a Interactions
(A) TUBB3 protein levels are reduced in TUBB3+/R262C (WT/KI) and TUBB3R262C/R262C (KI/KI) versus WT mice.
(B) TUBB3 R262C heterodimers incorporate into microtubules throughout cell bodies, neurites, and growth cones of dissociated cortical neurons as seen by
colocalization with tyrosinated a-tubulin and actin. Variable reductions in TUBB3 staining intensity are noted between WT and mutant neurons.
(C) Levels of de-tyrosinated a-tubulin are increased in brain lysates from mutant versus WT mice.
(D) Brain lysates from TUBB3R262C/R262C mice show increased microtubule polymerization at steady-state levels despite lower levels of b-tubulin. Mutant TUBB3
is detected in the pellets (p).
(E) Levels of Kif21a are reduced on TUBB3R262C/R262C mutant microtubules polymerized in vitro from brain lysates and incubated with ATP, whereas levels of Kif3a
remain constant.
(F) In vitro transcription and translation of WT and TUBB3 mutant heterodimers in rabbit reticulocyte lysate. Products analyzed by SDS (top) and nondenaturing
(native, bottom) gel electrophoresis and stained with an anti-V5 antibody against the C-terminal tag demonstrate that although transcription and translation are
not affected by the mutations, there can be significant and variable decreases in the yield of native heterodimers.
(G) Synthesized WT, R262H, E410K, and D417H/N heterodimers cycle with native bovine tubulin at equivalent efficiency; vertical lines denote removed empty
lanes.
*p < 0.05, **p < 0.001. Error bars denote standard error of the mean (SEM). See also Figure S3.expressed and translated at equivalent levels. Under native
conditions, R62Q, R262C, A302T, and R380C showed signifi-
cant reductions in heterodimer yield, whereas the remaining80 Cell 140, 74–87, January 8, 2010 ª2010 Elsevier Inc.four mutants generated moderate yields (Figure 4F). This latter
group was mixed with bovine brain tubulin and taken through
two successive rounds of microtubule polymerization and
Figure 5. TUBB3 Amino Acid Substitutions
and Phenotype-Genotype-Function Corre-
lations
(A) Schematic of the TUBB3 protein; arrows indi-
cate the location of each TUBB3 amino acid
substitution.
(B) Structure of the ab-tubulin heterodimer from
a rotated side view (PDB: 1JFF). a-tubulin is
dark-shaded on right, and the arrows on the left
point to each mutant residue, depicted in black,
on b-tubulin.
(C) Outside view of b-tubulin depicting each
mutant residue in black with the exception of
R62Q, which cannot be seen. The area proposed
for motor protein interactions is depicted as
a shaded gray oval. Residues R380, E410, and
D417 are found in helices H11 and H12, respec-
tively, on the external surface of b-tubulin. R262,
found in the loop between helix H8 and strand 7,
and A302, found in the loop following helix H9,
are positioned laterally to and below helices H12
and H11, respectively.
(D) Side interior view of b-tubulin showing the loca-
tion of each mutant residue in black, with the
exception of R380C, which is occluded by D417.
R62 is positioned in the H1-S2 loop (N-loop) that
forms lateral contacts with the M-loop of adjacent
protofilaments.
(E, top) Magnified image of b-tubulin depicting the
putative hydrogen bond between the arginine side
chain of R262 and the carbonyl oxygen of D417,
both of which are shown in a stick representation.
(E, middle and bottom) Both the R262C and
R262H substitutions are predicted to break the
hydrogen bond.
(F) Phenotype-genotype and summary of func-
tional data. AA = amino acid substitution; # ped =
number of pedigrees; # aff = number of affected
individuals; AC = anterior commissure hypoplasia;
CC = corpus callosum hypoplasia; BG = basal
ganglia dysgenesis; DD = developmental delay;
FW = facial weakness; PN = progressive axonal
sensorimotor polyneuropathy; CJC = congenital
joint contractures; HD = heterodimer formation;
HeLa = HeLa cell incorporation; BR = benomyl
resistance; MT dyn = microtubule dynamics
(HS = highly stable, S = stable); Kip3p/2p =
Kip3p and Kip2p microtubule plus-end accumulation (Y = decreased, [ = increased). + denotes present;  denotes absent; /+ denotes that only a subset
of subjects have the feature and/or the findings are mild; variable () denotes rare participants with the substitution without CFEOM3.
See also Figure S4, Table S2, and Movie S1.depolymerization. The ability of these mutant heterodimers to
co-cycle with native tubulin in vitro was equivalent to WT
(Figure 4G).
WT and mutant TUBB3-V5 expression constructs were next
transfected into HeLa cells that have well demarcated micro-
tubules. Immunostaining against the C-terminal V5 tag and
a-tubulin to detect the overall microtubule network revealed
incorporation of WT and mutant heterodimers. Cells expressing
R62Q and R262C TUBB3, however, had lower and more punc-
tuate microtubule incorporation, whereas A302T, R380C, and
the remaining mutants showed robust incorporation that was
similar to WT (Figure S3). Interestingly, patients harboring
R62Q or R262C have the mildest phenotypes, and this couldresult from lower amounts of mutant heterodimer incorporation
into microtubules compared to the other mutants. Thus,
although four disease-associated substitutions show scant het-
erodimer formation in vitro, all of the mutants can be incorpo-
rated into microtubules in mammalian cells, albeit at varying
levels.
TUBB3 Amino Acid Substitutions Are Located
in Different Structural Domains within b-Tubulin
TUBB3-disease substitutions reside in regions of b-tubulin
implicated in the regulation of microtubule dynamics, motor
protein trafficking, and interactions with MAPs (Li et al., 2002;
Lowe et al., 2001) (Figures 5A–5D, Movie S1). Residues R62Cell 140, 74–87, January 8, 2010 ª2010 Elsevier Inc. 81
and A302 reside in regions proposed to mediate lateral interac-
tions between longitudinal units of ab-tubulin heterodimers,
called protofilaments, which assemble to form cylindrical micro-
tubules. Lateral protofilament interactions aid microtubule
assembly and regulate dynamics (Nogales and Wang, 2006).
By contrast, residues R380, E410, and D417 are found in paired
a helices H11 (R380) and H12 (E410, D417) on the external
surfaces of microtubules that mediate interactions with
numerous motor proteins and MAPs (Al-Bassam et al., 2002;
Uchimura et al., 2006). Residue R262 is located in the loop
between helix H8 and strand 7 of b-tubulin below helix H12
and forms a putative hydrogen bond with H12 through the
carbonyl oxygen of residue D417. Upon mutation, this hydrogen
bond is abolished, potentially affecting the tertiary protein
structure and motor protein interactions with microtubules
(Figure 5E).
The locations of the TUBB3 substitutions suggest that some
could directly affect lateral protofilament interactions and micro-
tubule dynamics, whereas others may also perturb motor protein
interactions. Notably, these substitutions can result in diagnosti-
cally distinct phenotypes (Figure 5F), leading us to ask whether
they could alter TUBB3 function and cause dominant effects
upon microtubule behavior.
Insertion of Human TUBB3Mutations into the Yeast
b-Tubulin Locus Affects Cell Viability and Growth
The sequence and protein structure of b-tubulin is conserved
between different isotypes and across species (Luduena, 1993).
TUBB3 shares considerable homology with the single b-tubulin
isotype in budding yeast (Tub2p), including conservation of all
disease-associated residues (Figure S4). Budding yeast pro-
vides advantages for studying the behavior of microtubules
harboring TUBB3-disease substitutions (Reijo et al., 1994).
Mutations can be introduced into TUB2 by homologous recom-
bination, and a single b-tubulin isotype avoids the potential dimi-
nution of mutant phenotypes due to an abundance of other
tubulin isotypes.
To examine potential dominant effects of disease-associated
mutations, we inserted each into the yeast TUB2 locus, and two
independent heterozygous diploid strains for each mutation
were isolated and grown on nutrient-rich media. Heterozygous
diploids were recovered at the expected frequency and did not
display growth defects on rich medium, establishing that all of
the mutant heterozygous strains were viable. However, only
R62Q and R380C haploid spores were viable when present as
the sole copy of TUB2, and they grew slowly compared to WT
(Table S2).
TUBB3 Disease Substitutions Result in Benomyl
Resistance and Alter Microtubule Dynamics
To determine if mutant substitutions affect microtubule dynam-
ics, WT, heterozygous, and surviving haploid TUB2 mutant
strains were plated on media containing increasing amounts of
benomyl, a compound that destabilizes microtubules and
consequently inhibits cell division. Control strains grew normally
on complete media without benomyl but were modestly or com-
pletely inhibited by increasing drug concentrations. By contrast,
all mutant diploid strains demonstrated varying degrees of82 Cell 140, 74–87, January 8, 2010 ª2010 Elsevier Inc.benomyl resistance compared to WT (Figures S5A and S5B);
this is in contrast to a previously reported TUB2 mutagenesis
screen, in which alterations of conserved residues more often
caused benomyl supersensitivity than resistance (Reijo et al.,
1994). These results suggest that TUBB3 syndrome mutations
in Tub2p increase the stability of microtubules by rendering
them resistant to depolymerization. Finally, a heterozygous
diploid strain was generated in which one copy of TUB2 was
deleted. Unlike the TUBB3 substitutions, TUB2 haploinsuffi-
ciency resulted in benomyl supersensitivity (Figures S5A and
S5B). Thus, the TUBB3 substitutions do not result in complete
loss of TUB2 function and appear to cause dominant effects
on microtubule behavior.
Using time-lapse microscopy, we then asked how TUBB3
syndrome mutations alter microtubule dynamics. We monitored
astral microtubules in G1 cells given that microtubules are most
dynamic during G1 (Carminati and Stearns, 1997). GFP-Tub1p
(a-tubulin) labeled microtubules from heterozygous strains
R262C, R262H, A302T, and E410K, and haploid strains R62Q
and R380C were imaged because these residues reside within
different regions of the tubulin dimer.
Substitutions A302T, R62Q, and R380C resulted in similar and
significant changes to most measured parameters of microtu-
bule dynamics (Figures 6A–6C). Mutant microtubules were
more stable and had longer lifetimes compared to WT and spent
the majority of time in prolonged paused states instead of
growing and shortening. The frequency of transition to microtu-
bule depolymerization (catastrophe) was reduced, whereas the
frequency of transition to polymerization (rescue) was unaffected
in A302T heterozygotes and increased in R62Q and R380C
haploids. The rates of both polymerization and depolymerization
were significantly reduced. R380C microtubules appeared less
dynamic than R62Q and A302T microtubules and spent more
time in paused states, although WT tubulin in heterozygous
A302T cells might dampen stability. Thus, A302T, R62Q, and
R380C substitutions appear to increase the stability of microtu-
bules and significantly diminish overall dynamics (Movie S2).
A302 and R62 are found in loops within b-tubulin hypothesized
to regulate lateral protofilament interactions and thus might be
predicted to alter stability when mutated. In contrast, this finding
is somewhat unexpected for R380C, given that this residue
resides in H11, and to our knowledge this outer helix has not
been previously implicated in the regulation of microtubule
dynamics.
Diploid R262C, R262H, and E410K substitutions resulted in
changes to dynamics distinct from those described above
(Figures 6B and 6C). Microtubules in these heterozygous cells
spent similar amounts of time growing compared to WT, but
the average duration of individual growth events was prolonged
and astral microtubules in these strains were longer on average
(Figure S5C). The frequency of catastrophe events was only
slightly less, whereas the frequency of rescue events was signif-
icantly less than WT. Finally, these mutants showed a decreased
rate of polymerization and increased rate of depolymerization.
Thus, mutant R262C, R262H, and E410K astral microtubules
were often long and grew at reduced polymerization rates, fol-
lowed by a more rapid and complete disassembly to the spindle
pole body without recovery (Movie S2).
Figure 6. TUBB3 Disease Amino Acid
Substitutions Result in Changes toMicrotu-
bule Dynamic Instability
(A and B) Life-time history plots depicting the
lengths of microtubules (y axis) over time (x axis)
in G1 cells from (A) haploid WT and TUB2 mutants
and (B) heterozygous diploid WT and TUB2
mutants demonstrate that Tub2p substitutions
perturb microtubule dynamic instability. For WT
and each mutation, one microtubule representing
data from the collective analysis has been
selected and plotted.
(C) Summary table of individual dynamic instability
parameters. Number of events is listed in paren-
theses. *p < 0.05, **p < 0.001, ***p < 0.0001.
See also Figure S5, Table S2, and Movie S2.Mutation at Amino Acid Residues E410, D417, and R262
Result in a Loss of Kinesin Localization on Microtubule
Plus Ends
Amino acid residues E410 and D417 of yeast b-tubulin have been
identified as microtubule binding sites for conventional kinesin
(Kif5) in vitro (Uchimura et al., 2006), and we predict that R262
forms a hydrogen bond with D417, which is abolished by
R262C/H substitutions (Figure 5E). Perturbations to microtubule
dynamics observed in R262C/H and E410K cells, including the
faster rate of depolymerization and reduced rescue frequency,
are similar to those found following the deletion of Kip3p
(kip3D). Kip3p is a plus-end-directed kinesin motor found in
the nucleus and cytoplasm of yeast and is necessary to position
the mitotic spindle near the bud neck in dividing cells (DeZwaan
et al., 1997). kip3D, R262C/H, and E410K mutant cells often haveCell 140, 74–long microtubules that result in misposi-
tioning of the mitotic spindle away from
the bud neck (Gupta et al., 2006).
Altered dynamic instability resulting
from some TUBB3 substitutions might
be explained by reduced Kip3p-microtu-
bule interactions. Thus, we monitored
the behavior of Kip3p in vivo fused to
three tandem copies of yellow fluores-
cent protein (YFP) at its C terminus
(Kip3p-3YFP) in heterozygous mutant
and WT cells containing CFP-Tub1p
labeled microtubules. Localization of
Kip3p-3YFP on WT microtubules was
as previously reported, with strong inten-
sity detected on the plus-end tips and
discontinuous speckles along the length
of cytoplasmic microtubules (Figures 7A
and 7F) (Gupta et al., 2006). Time-lapse
video microscopy revealed a strong
reduction of Kip3p-3YFP along the
lengths and tips of growing microtubules
in R262C/H, E410K, and D417H/N cells
(Movie S3). Overall, R262C/H, E410K,
and D417H/N cells all had a 70%–
80% decrease in signal intensity com-pared to WT (Figures 7B–7J and 7U). We next examined the
plus-end localization of Kip2p-3YFP, as Kip2p is the second
major plus-end-directed kinesin motor found in the budding
yeast cytoplasm. Kip2p-3YFP localization was normal in WT
cells; it was absent from spindle pole bodies and was speckled
along the lengths and highly localized to the plus ends of cyto-
plasmic microtubules (Figures 7K and 7P) (Carvalho et al.,
2004). Mutant R262C/H, E410K, and D417H/N cells had a signif-
icant, albeit less dramatic and more variable, decrease in Kip2p-
3YFP plus-end localization compared to Kip3p (Figures 7L–7T
and 7V). There were no significant differences in the protein
levels of Kip3p-3YFP and Kip2p-3YFP between WT and mutant
cells to account for the quantitative differences (Figure S6). Thus,
the R262C, R262H, E410K, D417N, and D417H substitutions
result in a significant decrease in Kip3p-3YFP and Kip2p-3YFP87, January 8, 2010 ª2010 Elsevier Inc. 83
Figure 7. Kip3p and Kip2p Levels Are
Reduced at the Plus Ends of Mutant Micro-
tubules
Merged Z stack images showing the levels of
Kip3p-3YFP (A–E, red) and Kip2p-3YFP (K–O,
red) on WT and mutant microtubules labeled with
CFP-Tub1p (a-tubulin, green) in budding yeast.
Corresponding Kip3p (F–J) and Kip2p (P–T) YFP
channels with signal intensities adjusted equally
for WT and each TUB2 mutant are provided for
comparison. In WT cells, Kip3p-3YFP (A and F)
and Kip2p-3YFP (K and P) are speckled along the
length and accumulate at the plus ends of grow-
ing cytoplasmic microtubules labeled by white
arrows. In contrast, mutant R262C (B), R262H
(C), E410K (D), and D417N (E) heterozygous diploid
cells all have a significant reduction of Kip3p-3YFP
along the lengths and plus ends of cytoplasmic
microtubules (white arrows), and Kip2p-3YFP is
speckled along the length but reduced or absent
on cytoplasmic microtubule plus ends (white
arrows) in R262C (L), R262H (M), E410K (N), and
D417H (O) heterozygous diploid cells.
Graphs depicting the overall mean levels of Kip3p-
3YFP (U) and Kip2p-3YFP (V) on microtubule plus
ends in WT and mutant cells. *p < 0.05, **p <
0.001, ***p < 0.0001. Error bars denote SEM.
See also Figure S6, Table S2, and Movie S3.accumulation on cytoplasmic microtubule plus ends, suggesting
that kinesin interactions on microtubules are reduced in humans
harboring these amino acid substitutions. These data provide
in vivo evidence to support previous in vitro studies (Uchimura
et al., 2006) implicating E410 and D417, as well as identifying
an additional residue, R262, as important amino acids for pro-
per microtubule-kinesin interactions. These findings also sup-
port diminished KIF21A microtubule interactions found in
TUBB3R262C/R262C mice (Figure 4E).
The localization of Kip3p-3YFP and Kip2p-3YFP on the plus
ends of cytoplasmic microtubules was not significantly altered
between WT, R62Q and A302T heterozygous mutant cells
(Figures 7U and 7V), and these residues are distal from known
kinesin-microtubule interaction sites. Cytoplasmic microtubules
in heterozygous R380C cells had an approximately 50% increase84 Cell 140, 74–87, January 8, 2010 ª2010 Elsevier Inc.in the amount of Kip3p-3YFP at the plus
ends but a nonsignificant increase in the
amount of Kip2p-3YFP (Figures 7U and
7V). Thus, residues R62Q, A302T, and
R380C all diminish microtubule dynamics
in a similar fashion and do not significantly
reduce the levels of kinesin on the plus
ends of microtubules.
DISCUSSION
Phenotype-Genotype Correlations
in the TUBB3 Syndromes Support
a Dominant Etiology
We have identified TUBB3 as the mutated
gene underlying a series of autosomal
dominant disorders of axon guidance that we collectively call
the TUBB3 syndromes. In 29 unrelated families, we identified
eight unique heterozygous missense mutations that alter six
amino acid residues. Phenotype-genotype correlations are
emerging for these syndromes, and although the TUBB3 pheno-
types limited to CFEOM3 and polyneuropathy often segregate in
autosomal dominant families, those with more severe clinical
findings typically arise de novo. Overall, most adults with isolated
CFEOM3 have R262C or, less commonly, R62Q or A302T substi-
tutions. Some children with isolated CFEOM3, however, harbor
the D417N substitution and are at risk of developing a polyneur-
opathy in their teens or twenties. CFEOM3 with developmental
delay, CC agenesis, and basal ganglia dysmorphisms in the
absence of facial weakness may be predictive of the R380C sub-
stitution. Association of severe CFEOM3 with facial weakness,
developmental delay, moderate to severe CC dysgenesis, and
likely a late-onset polyneuropathy predicts the E410K substitu-
tion, while the addition of finger contractures, basal ganglia dys-
morphisms, and early onset polyneuropathy would suggest
R262H or D417H substitutions.
Multiple findings suggest that the mutations underlying the
TUBB3 syndromes primarily alter microtubule function in a domi-
nant fashion, although we cannot rule out partial loss of function
for some. First, recurrent missense mutations in the absence of
truncating mutations are most consistent with altered rather
than loss of protein function as a primary genetic etiology.
Second, facial paralysis and progressive sensorimotor polyneur-
opathy occur only in those individuals harboring R262H, E410K,
D417H/N, the four mutations that permit heterodimer formation
and efficient microtubule incorporation, and have dominant
effects upon microtubule function by perturbing kinesin interac-
tions in yeast. Third, among the four mutations that result in scant
heterodimer formation, A302T and R380C have considerably
more microtubule incorporation in mammalian cells and cause
more severe phenotypes than R62Q and R262C. Finally,
R262C and R262H result in relatively isolated CFEOM3 and
a severe TUBB3 phenotype, respectively; these two substitu-
tions are distinguished because R262H permits much more
efficient heterodimer formation and microtubule incorporation
than R262C both in vitro and in mammalian cells. Thus, more
severe phenotypes and developmental disabilities that correlate
with particular mutations might reflect a greater extent of mutant
heterodimer incorporation and the specific nature of the domi-
nant effect (i.e., dynamics, protein interactions).
Motor Protein Trafficking Defects Result in Progressive
Axonal Neuropathy
Progressive axonal neuropathies can result from inactivating
mutations in kinesin and dynein accessory proteins, underscor-
ing the vulnerability of motor neurons and peripheral axons to
protein trafficking defects (Chevalier-Larsen and Holzbaur,
2006). The TUBB3 syndromes now demonstrate that tubulin
mutations resulting in secondary motor protein transport defects
can also cause axonal neuropathies. TUBB3 expression is
maintained at high levels only in the adult PNS (Jiang and Oblin-
ger, 1992), supporting a role for TUBB3 in health and mainte-
nance of peripheral motor and sensory axons. This role is in
addition to the function of TUBB3 in cranial nerve development,
and perturbations in protein trafficking caused by a subset of
TUBB3 substitutions may also explain, in part, the cellular
etiology of CFEOM3. Notably, recurrent dominant mutations in
KIF21A result in CFEOM1 and, in rare families, CFEOM3
(Yamada et al., 2004). Our findings in mice suggest that muta-
tions in TUBB3 can diminish KIF21A-microtubule interactions,
possibly accounting for oculomotor nerve axon guidance
defects.
TUBB3 Is Required for Proper Axon Guidance
Neuroimaging, clinical manifestations of cranial motor nerve
misrouting, and the phenotypic analysis of a TUBB3 disease
mouse model elucidate a critical role for TUBB3 in proper axon
guidance. Throughout nervous system development, differenti-
ating neurons require dynamic populations of microtubules inorder to appropriately respond to growth and guidance cues
(Gordon-Weeks, 2004; Kalil and Dent, 2005). Because TUBB3
is the most dynamic b-tubulin isotype and the only one with
expression primarily restricted to the CNS and PNS (Katsetos
et al., 2003), it has been hypothesized that the dynamic proper-
ties of TUBB3 could be required for specific developmental
processes (Panda et al., 1994). We expand upon these earlier
observations by demonstrating that microtubule stability is
increased in homozygous R262C mice, a finding that could result
from the combined effects of Tubb3 heterodimer loss and the
remaining mutant heterodimers. Dynamic changes could be
exacerbated further by mutant heterodimers that diminish micro-
tubule dynamics and incorporate at higher levels (R380C), result-
ing in more severe axon guidance phenotypes.Tubulin Isotypes Have Divergent Cellular Functions
Certain aspects of the TUBB3 syndromes, including CC dysgen-
esis and basal ganglia dysmorphisms, converge with those
resulting from heterozygous missense mutations in TUBA1A
and TUBB2B in humans (Jaglin et al., 2009; Keays et al., 2007).
Each of these three tubulin isotypes are highly expressed in post-
mitotic differentiating neurons and the phenotypic similarities
suggest that they have important overlapping functions (Coksay-
gan et al., 2006; Jaglin et al., 2009; Liu et al., 2007). However, the
primary brain malformations resulting from mutations in TUBA1A
and TUBB2B are lissencephaly, pachygyria, and/or gray matter
heterotopias that result from cell migration defects. By contrast,
humans and mice with TUBB3 substitutions do not show signs of
cortical cell migration defects, and a recent study of TUBA1A
mutation-negative subjects ascertained on the basis of agyria
and pachygyria failed to identify mutations in TUBB3 (Poirier
et al., 2007) and instead identified TUBB2B (Jaglin et al., 2009).
Remarkably, TUBB2B and TUBB3 are the major b-tubulin iso-
types expressed in the nervous system and share 90% protein
sequence homology, including all disease-associated amino
acids. These isotypes differ, however, in the sequence of their
C-terminal tails, dynamic behavior in vitro, and unique posttrans-
lational modifications (Banerjee et al., 1990; Khan and Luduena,
1996), suggesting that functional differences between these iso-
types may account for phenotypic distinctions in humans and
mice. Our results now greatly expand upon previous observa-
tions that different b-tubulin isotypes may have evolved in higher
vertebrates to serve specific cellular functions (Luduena, 1993)
and support a critical role for TUBB3 in axon guidance.EXPERIMENTAL PROCEDURES
Detailed methods can be found in the Extended Experimental Procedures
available online.
Clinical Genetic Studies
Probands were ascertained based on affection with CFEOM. Participants
were enrolled by the Engle Laboratory at Children’s Hospital Boston or by
collaborating laboratories following appropriate Institutional Review Board
approval and informed consent. Clinical data were obtained from participants
and medical providers. Genetic linkage and mutation detection by direct
sequencing and DHPLC were performed as previously described (Doherty
et al., 1999; Miyake et al., 2008) and using NCBI reference sequences
NM_006086 and NT_010542.Cell 140, 74–87, January 8, 2010 ª2010 Elsevier Inc. 85
Magnetic Resonance Imaging
Diagnostic MRI scans were reviewed from participants with each TUBB3
substitution except D417H. Images are T1 (B–E, G, B0, F0), T2 (A, F, H, J-N,
A0–D0, G0, H0), Flair (I). Orbital MRI was performed as described previously
(Demer et al., 2005).
Mouse Histology, Whole-Mount Neurofilament Staining,
and Dissociated Neuronal Cultures
E18.5 embryonic brains on mixed 129/B6 and pure 129S6 backgrounds were
fixed in 4% paraformaldehyde and embedded for cryo- or paraffin sectioning.
Ten to twelve micrometer sections were blocked with 5% normal goat/donkey
serum and 0.1% Triton in PBS at room temperature for 1 hr and incubated with
primary antibody in 1% serum and 0.01% Triton at 4C overnight. Secondary
antibody was added at room temperature for 1 hr.
Microtubule Repolymerization Assay
E18 whole brains from WT, heterozygous, and homozygous mutant mice were
homogenized in BRB80 buffer and centrifuged at 50,000g at 4C for 30 min.
One millimolar GTP was added to supernatant and microtubules were poly-
merized for 30 min at 37C. Samples were layered on a 30% sucrose cushion
and centrifuged for 20 min at 37C at 100,000 g to pellet the microtubules.
Copurification of Kinesin with Microtubules
E18 brains from WT and homozygous mutant mice were homogenized with
a glass homogenizer in BRB80 buffer containing protease inhibitors and
PMSF and incubated on ice for 20 min. A tubulin-rich fraction was obtained
by centrifuging the lysates at 4C for 30 min at 50,000 g. One millimolar ATP,
1 mM GTP, and 10 mM taxol were added to the supernatants and incubated
at 37C for 30 min. Samples were then layered on top of a 30% sucrose cushion
and centrifuged for 20 min at 37C at 100,000 g. Pellets were resuspended in
SDS buffer and run on SDS NuPAGE 8%–12% Bis-Tris gels (Invitrogen).
In Vitro Heterodimer Formation and Cycling
One microgram of plasmid DNA was added to 50 ml of reticulocyte cocktail
according to manufacturer’s instructions (Promega TNT T7 Coupled Reticulo-
cyte Lysate), and the reactions were incubated at 30C for 90 min. Following
incubation, the products were chased with 300 ng bovine brain tubulin and
1 mM MgCl2 and GTP for 30 min at 37
C, and 2 ml and 10 ml from the overall
reactions were run on SDS NuPAGE 8%–12% Bis-Tris (Invitrogen) and Native-
PAGE 4%–16% Bis-Tris Gels (Invitrogen), respectively. WT and mutant
TUBB3 heterodimers were detected with a monoclonal V5 antibody (Invitro-
gen) against the C-terminal tag. Remaining products were cycled with bovine
brain tubulin.
Mutation Modeling
Each TUBB3 substitution was plotted on the solved protein structure for the
ab-tubulin heterodimer (Protein Data Bank [PDB]: 1JFF) using PyMOL soft-
ware (1.1r1, http://www.pymol.org/). Hydrogen bonds were predicted using
the bond distance measurement function and were also modeled using the
Swiss-Pdb Viewer (DeepView). The protein model movie was created using
PyMOL.
Yeast In Vivo Microtubule Dynamics
Cells were seeded overnight in SD-complete media (0.67% yeast nitrogen
base without amino acids, 5% glucose, 0.5% casamino acids) and allowed
to grow at 24C. The next morning, cells were reseeded and grown at 24C
to mid-log phase. One milliliter of cells were pelleted, resuspended in
SD-complete media, imaged at room temperature (26C) on an Axio Image
MI (Zeiss) scope with a 633 Plan Fluor 1.4 N.A. objective, and captured using
a Coolsnap HQ camera (Photometrics). The typical acquisition protocol
acquired five z-series fluorescent images at 0.75 mm axial steps and one differ-
ential interference contrast (DIC) image corresponding to the central fluores-
cent image. Time-lapse image series were acquired at 8 s intervals.
Kip3p-3YFP and Kip2p-3YFP Microtubule Plus-End Localization
Mutant and WT CFP-Tub1p-expressing cells containing either Kip3p-3YFP or
Kip2p-3YFP were grown and imaged as described above in the in vivo micro-86 Cell 140, 74–87, January 8, 2010 ª2010 Elsevier Inc.tubule dynamics section. Seven z-series images were merged into a single
projection image (maximum) using deconvolution microscopy and the nearest
neighbor algorithm function in Slidebook software (Intelligent Imaging Innova-
tions, CO). In randomly selected fields, the plus ends of all identifiable micro-
tubules in multiple cells in all phases of the cell cycle were marked with a circle
of equal radius, and the average plus-end intensity was then calculated using
quantification software (Slidebook). At least two clones from WT and mutant
strains were analyzed on at least two separate days, and net signal intensities
from microtubule plus ends and cell backgrounds were determined by aver-
aging the values obtained from the total population on each day.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, three tables, three movies, and references and can be found with
the article online at doi:10.1016/j.cell.2009.12.011.
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